Zurich Cantonal Bank
IART icon

Zurich Cantonal Bank’s Integra LifeSciences IART Stock Holding History

Zurich Cantonal Bank’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-19,014
Closed -$236K – 3003
2025
Q4 		$236K Buy
+19,014
New +$253K ﹤0.01% 2168

Other funds holding IART

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Zurich Cantonal Bank's IART Position: Q2 2026 in Review

Zurich Cantonal Bank held its Integra LifeSciences (IART) position steady in Q2 2026 at 28,785 shares worth $517K. The position accounts for ﹤0.01% of the portfolio, ranked #1919.

Zurich Cantonal Bank first reported a position in IART in Q2 2013 and has held it in 47 quarters since. The position peaked at $1.61M in Q3 2013. 212 funds tracked by Wall St. Rank hold IART as of Q2 2026.

  • Zurich Cantonal Bank held 28,785 shares of Integra LifeSciences worth $517K as of Q2 2026.
  • Zurich Cantonal Bank left its Integra LifeSciences share count unchanged in Q2 2026.
  • Integra LifeSciences made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #1919 holding.
  • Zurich Cantonal Bank first reported a position in Integra LifeSciences in Q2 2013 and has held it in 47 quarters since.
  • Zurich Cantonal Bank's Integra LifeSciences position peaked at $1.61M in Q3 2013.
  • 212 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.